
Vasopressin antagonist efficacy and safety in volume-overloaded critically ill patients: a new therapeutic alternative
Author(s) -
Jesús Ruiz-Ramos,
Paula Ramírez,
Manel Porcar,
Mónica Gordon,
Esther Villarreal,
Armando Pinos,
M. Meliàn Sosa,
Álvaro Castellanos-Ortega
Publication year - 2018
Publication title -
european journal of hospital pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.313
H-Index - 14
eISSN - 2047-9964
pISSN - 2047-9956
DOI - 10.1136/ejhpharm-2018-001664
Subject(s) - tolvaptan , medicine , refractory (planetary science) , volume overload , diuretic , observational study , intravascular volume status , diuresis , vasopressin antagonists , anesthesia , vasopressin , intensive care medicine , heart failure , antagonist , renal function , hemodynamics , receptor , physics , astrobiology
To assess tolvaptan's efficacy and safety in critical care patients with volume overload.